The biosimilars market is expected to reach $23.63 billion by 2023 from $5.95 billion in 2018, at a CAGR of 31.7 percent. Factors driving the growth of this market include increasing demand for biosimilar drugs due to their cost-effectiveness, rising incidence of chronic diseases, and strategic collaborations resulting in enhanced productivity and clinical trial activities. The recombinant…